In the last 12 months, insiders at NORTHWEST BIOTHERAPEUTICS INC ($NWBO) filed 13 transactions with the SEC: 0 open-market purchases totaling $0 and 4 sales totaling $469,430. Net insider sentiment: net selling.
NORTHWEST BIOTHERAPEUTICS INC operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- MALIK NAVID (Director) — 4 transactions totaling $469,430
- BOSCH MARNIX L (Chief Technical Officer) — 1 transaction totaling $29,839
- BOSCH MARNIX L (CHIEF TECHNICAL OFFICER) — 1 transaction totaling $0
- BOYNTON ALTON L (CHIEF SCIENTIFIC OFFICER) — 7 transactions totaling $0
View all SEC Filings for NORTHWEST BIOTHERAPEUTICS INC (NWBO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 29, 2024 | BOYNTON ALTON L | CHIEF SCIENTIFIC OFFICER | G | STOCK OPTIONS | 1000000 | $0.00 | 967,065.0000 | 1,214,316 | 50.84% | 82.35% |
| Aug. 9, 2024 | BOSCH MARNIX L | CHIEF TECHNICAL OFFICER | G | STOCK OPTIONS | 3000000 | $0.00 | 4,549,157.0000 | 1,214,316 | 39.74% | 100.00% |
| Aug. 8, 2024 | BOYNTON ALTON L | CHIEF SCIENTIFIC OFFICER | G | STOCK OPTIONS | 1000000 | $0.00 | 1,967,065.0000 | 1,214,316 | 33.70% | 82.35% |
| July 26, 2024 | MALIK NAVID | Director | S | Stock Option | 657895 | $0.38 | 23,339,393.0000 | 1,214,316 | 2.74% | 54.18% |
| Nov. 16, 2023 | MALIK NAVID | Director | S | Common Stock | 125000 | $0.84 | 445,000.0000 | 1,134,359 | 39.06% | 11.02% |
| Nov. 17, 2023 | MALIK NAVID | Director | S | Common Stock | 150000 | $0.82 | 295,000.0000 | 1,134,359 | 103.45% | 13.22% |
| Nov. 17, 2023 | MALIK NAVID | Director | S | Common Stock | 295000 | $0.82 | 0.0000 | 1,134,359 | 0.00% | 26.01% |
| April 3, 2023 | BOSCH MARNIX L | Chief Technical Officer | A | Common Stock | 119355 | $0.25 | 119,355.0000 | 1,074,902 | 9999.99% | 11.10% |
| April 4, 2023 | BOYNTON ALTON L | CHIEF SCIENTIFIC OFFICER | G | STOCK OPTIONS | 6794191 | $0.00 | 2,967,065.0000 | 1,074,902 | 69.60% | 100.00% |
| May 26, 2022 | BOYNTON ALTON L | CHIEF SCIENTIFIC OFFICER | G | COMMON STOCK OPTIONS | 4900000 | $0.00 | 9,761,256.0000 | 959,251 | 33.42% | 100.00% |
| July 27, 2022 | BOYNTON ALTON L | CHIEF SCIENTIFIC OFFICER | G | COMMON STOCK OPTIONS | 3000000 | $0.00 | 9,761,256.0000 | 1,003,976 | 23.51% | 100.00% |
| Dec. 6, 2022 | BOYNTON ALTON L | CHIEF SCIENTIFIC OFFICER | G | COMMON STOCK OPTIONS | 4500000 | $0.00 | 9,761,256.0000 | 1,040,982 | 31.55% | 100.00% |
| Dec. 6, 2022 | BOYNTON ALTON L | CHIEF SCIENTIFIC OFFICER | G | COMMON STOCK OPTIONS | 4500000 | $0.00 | 9,761,256.0000 | 1,040,982 | 31.55% | 100.00% |